The effect of the use of omeprazole versus famotidine on the kidney transplant function: a randomized controlled study
Abstract Tacrolimus is metabolized in the liver with the participation of cytochrome P450 isoforms 3A4 and 3A5 (CYP3A4, CYP3A5). Omeprazole, unlike famotidine, is a substrate and inhibitor of CYP2C19, CYP3A4, CYP3A5 enzymes. The aim of the study is to compare the effect of omeprazole and famotidine...
Saved in:
Main Authors: | Miłosz Miedziaszczyk, Marek Karczewski, Ilona Idasiak-Piechocka |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-85534-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of efficacy and safety of generic tacrolimus (Suprotac®) compared to reference tacrolimus (Prograf<sup>®</sup>) in kidney transplantation: a phase IV study
by: Behzad Einollahi, et al.
Published: (2025-01-01) -
The Promising Effect of Tocilizumab on Chronic Antibody-Mediated Rejection (cAMR) of Kidney Transplant
by: Łukasz Świątek, et al.
Published: (2025-01-01) -
Pregnancy after kidney and liver transplantation
by: A Wise, et al.
Published: (2024-04-01) -
The state of combined thoracoabdominal triple-organ transplantation in the United States
by: Emily G. Dunbar, BS, et al.
Published: (2025-02-01) -
A Global Survey of Self-Reported Cancer Screening Practices by Health Professionals for Kidney Transplant Candidates and Recipients
by: Nida Saleem, et al.
Published: (2025-01-01)